Renée Galá B.S. Math ’94 named CEO of Jazz Pharmaceuticals

Renée Galá, who received a B.S. in Mathematics from Vanderbilt in 1994, has been announced as the new CEO of Jazz Pharmaceuticals. Galá is one of a handful of women who lead a major pharmaceutical company.
Before starting at Jazz, Galá held chief financial officer positions at Grail and Theravance. She also worked at Eli Lilly. For more details see:
https://www.fiercepharma.com/pharma/new-cadence-jazz-renee-gala-replaces-16-year-ceo-bruce-cozadd
Congratulations, Renée!